NEWRON PHARMACEUTICALS S.P.A.

Insiders Newron Pharmaceuticals S.p.A.

Equities

NWRN

IT0004147952

Market Closed - Swiss Exchange Other stock markets 16:31:47 25/06/2024 BST			5-day change	1st Jan Change
9.56 ^CHF	-12.77%		-9.98%	+93.13%

05-13	Newron Pharmaceuticals S.P.A Reports Compelling Additional Data Documenting the Efficacy of Evenamide in Pivotal Study 008A in Poorly Responding Schizophrenia Patients	CI
04-30	Newron Pharmaceuticals S.p.A. Announces Positive Top-line Results From Potentially Pivotal Phase II/III Study 008A With Evenamide in Schizophrenia Patients	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member	04-16	CI
Newron Pharmaceuticals S.p.A. Appoints Margarita Chavez as Board Advisor	02/10/23	CI
Newron Pharmaceuticals S.P.A. Announces Marco Caremi, Executive Vice President Business Development Will Leave the Company as Per End of June 2023	02/05/23	CI
Newron Pharmaceuticals Promotes Finance VP to CFO	02/05/23	MT
Newron Pharmaceuticals S.p.A. Announces Resignation of Robert Leslie Holland as Non-Executive Member of the Board of Directors	01/12/21	CI
Newron Pharmaceuticals S.p.A. Announces Change in Board of Directors	08/02/18	CI
Newron Pharmaceuticals S.p.A Announces Management Changes	23/12/16	CI
Newron Pharmaceuticals S.p.A. Announces Board Appointments	18/04/13	CI
Newron Pharmaceuticals S.p.A. Appoints Roberto Consonni as Non Executive Director	03/07/12	CI
Newron Pharmaceuticals S.p.A. Announces Changes in Management Team, Effective as of May 31, 2012	14/05/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer